Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorios farmaceuticos, s.a. (lafsa) - Ácido fÓlico - Ácido fÓlico....5mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorios farmaceuticos, s.a. (lafsa) - loperamida hidrocloruro - loperamida hidrocloruro....2.00 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorios farmaceuticos, s.a. (lafsa) - terpina hidratada usp - terpina hidratada usp....0.0165g / aceite esencial de eucalipto usp....0.00415g / tintura de eucalipto....0.125g / mentol cristal usp....0.0065g / difenhidramina hcl....0.0105g

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorios farmaceuticos, s.a. (lafsa) - ciproheptadina hcl - ciproheptadina hcl....4.0 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorios farmaceuticos, s.a. (lafsa) - Ácido ascÓrbico - Ácido ascÓrbico....500.0 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorios farmaceuticos, s.a. (lafsa) - sulfametizol - sulfametizol....250.00 mg / tetraciclina hcl....250.00 mg / fenazopiridina....50.00 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorios farmaceuticos, s.a. (lafsa) - atenolol - atenolol....100.00 mg.

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorios farmaceuticos, s.a. - ciproheptadina hcl - ciproheptadina hcl....2 mg

Ireland - English - HPRA (Health Products Regulatory Authority)

laboratorios liconsa, s.a. - terbinafine - tablets - 250 milligram - antifungals for systemic use - antifungals for systemic use - it is indicated in the treatment of the following skin and nail fungal infections: treatment of tinea corporis, tinea cruris and tinea pedis, when oral therapy is considered appropriate depending on the site, severity or extent of the infection and for the treatment of onychomycosis caused by dermatophytes

European Union - English - EMA (European Medicines Agency)

laboratorios hipra s.a - live ge- tk- double-gene-deleted bovine herpes virus type 1, strain ceddel: 106.3–107.3 ccid50 - immunologicals - cattle - for the active immunisation of cattle from three months of age against bovine herpes virus type 1 (bohv-1) to reduce the clinical signs of infectious bovine rhinotracheitis (ibr) and field virus excretion.onset of immunity: 21 days after completion of the basic vaccination scheme.duration of immunity: 6 months after completion of the basic vaccination scheme